Trending...
- "The Mystery of Emma Thorn" Earns Nomination & Official Selection of the New Media Film Festival
- California: Governor Newsom highlights mental health resources for veterans as Middle East conflict continues
- New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that senior management is scheduled to present at the following investor conferences:
Event: Wells Fargo Healthcare Conference
Date: Thursday, September 8, 2022
Time: 10:25 a.m. Eastern Time
Event: Morgan Stanley Healthcare Conference
Date: Monday, September 12, 2022
Time: 11:05 a.m. Eastern Time
Interested parties may access a live and archived webcast of each presentation by visiting the Axonics investor relations website.
More on The Californer
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
More on The Californer
Axonics sacral neuromodulation (SNM) systems provide patients suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company's best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
Contacts
Neil Bhalodkar
949-336-5293
ir@axonics.com
Event: Wells Fargo Healthcare Conference
Date: Thursday, September 8, 2022
Time: 10:25 a.m. Eastern Time
Event: Morgan Stanley Healthcare Conference
Date: Monday, September 12, 2022
Time: 11:05 a.m. Eastern Time
Interested parties may access a live and archived webcast of each presentation by visiting the Axonics investor relations website.
More on The Californer
- As AI Accelerates Software Delivery, ThinkSys Introduces Zero Critical Bugs Guarantee
- R&B Singer Nicc LaRue releases anticipated single, "GOLD"
- Tint Academy Training in Dallas Texas: Learn Window Tint & PPF Installation
- $IBG accelerates toward transformative merger with BlockFuel as $6 million raise fuels dual-industry growth strategy: N A S D A Q: IBG
- High-Growth Power Infrastructure Play Targets AI Boom: 1606 Corp. Executes Aggressive Texas Expansion Strategy: 1606 Corp. (Stock Symbol: CBDW) $CBDW
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
More on The Californer
- Accelerating the Transformation into a U.S. Nuclear Fuel Cycle Leader: Frontier Nuclear and Minerals Inc. (N A S D A Q: FNUC)
- Ozz Metals Ltd Secures 1-Tonne Gold Offtake Agreement
- California: Governor Gavin Newsom announces appointments 3.17.2026
- Owl Publishers Expands Support for Authors with Complete Book Publishing Services
- Jet Set: The Ultimate Coachella Afterparty
Axonics sacral neuromodulation (SNM) systems provide patients suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company's best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
Contacts
Neil Bhalodkar
949-336-5293
ir@axonics.com
Filed Under: Business
0 Comments
Latest on The Californer
- Geyser Data Announces Exclusive Value-Added Distributor in Brazil, Extreme Digital Solutions
- New Epstein Book Details Explosive New Factoids about Epstein-Trump
- Innovative Environmental Technologies Unveils New Website Featuring Free AI Tools for the Environmental Industry
- CCHR Warns: Psychiatric Diagnoses Without Biological Proof Now Used to Justify Euthanasia
- ISSE Services Named Awardee on $151B SHIELD Contract
- Connect Announces 2026 Class of Cool Companies Highlighting San Diego's Venture-Ready Startups
- Pervaziv AI Launches Cortex 3.0 - World's First Cross-Browser & Cross-IDE AI Coding & Security Agent
- Impact Filtration Appoints Alejandro Sturniolo as Head of Sustainability to Engineer High-Performance, Water-Positive Infrastructure
- Machine Vision Products adds Team A.T.E to its North American sales channel
- Recording Academy Member Joanna Pearl Honors Kim Cousins at 77th Annual Lake Elsinore Gala
- Twitch Streamer Caiuwus Emerges From "Streamer University" Spotlight With New Ambitions for 2026
- The Best Cartier Bracelet Dupes to Buy Right Now
- Xycota Biosciences Announces Nature Portfolio Publication Supporting Brain Repair Platform Targeting FTD and ALS
- Long Beach Parks, Recreation and Marine to Update Operating Hours and Programming at City Gyms
- Fabian Starr Announces "Back to the Arcade" Remix Album
- Attn: Book Critics, Poetry Lovers & Rock Stars: Help Rescue All these Great Poems from Obscurity
- Brainfyre Public Relations Introduces Program to Help Founders Build Media Readiness
- 106 Years Strong: The Liberty Group Celebrates a Century-Plus of Service and Unveils a Unified Family of Companies
- What they are saying: Overwhelming support for Governor Newsom's historic expansion of California's behavioral health capacity and treatment
- Airport Transportation Reaches All Five Continents Through Global Transportation Partner Network